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One Sentence Summary: Virus genomes reveal the establishment of Zika virus in Brazil and 90 
the Americas, and provide an appropriate timeframe for baseline (pre-Zika) microcephaly in 91 
different regions. 92 93 
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Zika virus (ZIKV) transmission in the Americas was first confirmed in May 2015 in 94 
Northeast Brazil1. Brazil has the highest number of reported ZIKV cases worldwide 95 
(>200,000 by 24 Dec 20162) and the most cases associated with microcephaly and other 96 
birth defects (2,366 confirmed by 31 Dec 20162). Following the initial detection of ZIKV 97 
in Brazil, >45 countries in the Americas have reported local ZIKV transmission, with 24 98 
of these reporting ZIKV-associated severe disease3. Yet the origin and epidemic history 99 
of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this 100 
information for interpreting observed trends in reported microcephaly. To address this 101 
we generated 54 complete or partial ZIKV genomes, mostly from Brazil, and report 102 
data generated by a mobile genomics lab that travelled across Northeast (NE) Brazil in 103 
2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses 104 
of viral genomes with ecological and epidemiological data estimate that ZIKV was 105 
present in NE Brazil by February 2014 and likely disseminated from there, nationally 106 
and internationally, before the first detection of ZIKV in the Americas. Estimated dates 107 
of the international spread of ZIKV from Brazil indicate the duration of pre-detection 108 
cryptic transmission in recipient regions. NE Brazil’s role in the establishment of ZIKV 109 
in the Americas is further supported by geographic analysis of ZIKV transmission 110 
potential and by estimates of the virus’ basic reproduction number.  111 
 112 
Previous phylogenetic analyses indicated that the ZIKV epidemic was caused by the 113 
introduction of an Asian genotype lineage into the Americas around late 2013, at least one 114 
year before its detection there4. An estimated 100 million people in the Americas are 115 
predicted to be at risk of acquiring ZIKV once the epidemic has reached its full extent5. 116 
However, little is known about the genetic diversity and transmission history of the virus in 117 
Brazil6. Reconstructing ZIKV spread from case reports alone is challenging because 118 
symptoms (typically fever, headache, joint pain, rashes, and conjunctivitis) overlap with those 119 
caused by co-circulating arthropod-borne viruses7 and due to a lack of nationwide ZIKV-120 
specific surveillance in Brazil before 2016. 121 
To address this we undertook a collaborative investigation of ZIKV molecular epidemiology 122 
in Brazil, including results from a mobile genomics laboratory that travelled through NE 123 
Brazil during June 2016 (the ZiBRA project; http://www.zibraproject.org). Of five regions of 124 
Brazil (Fig. 1a), the Northeast region (NE Brazil) has the most notified ZIKV cases (40% of 125 
Brazilian cases) and the most confirmed microcephaly cases (76% of Brazilian cases, to 31 126 
Dec 20162), raising questions about why the region is so severely affected8. Further, NE 127 
Brazil is the most populous region of Brazil that also has potential for year-round ZIKV 128 
transmission9. With support from the Brazilian Ministry of Health and other institutions 129 
(Acknowledgements), the ZiBRA lab screened 1330 samples (almost exclusively serum or 130 
blood) from patients residing in 82 municipalities across five federal states (Fig. 1; Extended 131 
Data Table 1a). Samples provided by the public health laboratory of each state (LACEN) and 132 
FIOCRUZ were screened for the presence of ZIKV by real time quantitative PCR (RT-133 
qPCR). 134 
On average, ZIKV viremia persists for 10 days after infection; symptoms develop after ~6 135 
days and can last 1-2 weeks10. In line with previous observations in Colombia11, we found that 136 
RT-qPCR+ samples in NE Brazil were, on average, collected only two days after onset of 137 
symptoms. The median RT-qPCR cycle threshold (Ct) value of positive samples was 138 
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correspondingly high, at 36 (Extended Data Fig. 1a,b). For NE Brazil, the time series of RT-139 
qPCR+ cases was positively correlated with the number of weekly-notified cases (Pearson’s 140 
ρ=0.62; Fig. 1b). 141 
The ability of the mosquito vector Aedes aegypti to transmit ZIKV is determined by 142 
ecological factors that affect adult survival, viral replication, and infective periods12. To 143 
investigate the receptivity of Brazilian regions to ZIKV transmission we used a measure of 144 
vector climatic suitability, derived from monthly temperature, relative humidity, and 145 
precipitation data9. Using linear regression we find that, for each Brazilian region, there is a 146 
strong association between estimated climatic suitability and weekly notified cases (Figs. 147 
1b,1c; adjusted R2>0.84, P<0.001; Extended Data Table 1b). Similar to previous findings 148 
from dengue virus outbreaks13,14, notified ZIKV cases lag climatic suitability by ~4 to 6 149 
weeks in all regions, except NE Brazil, where no time lag is evident. Despite these 150 
associations, numbers of notified cases should be interpreted cautiously because (i) co-151 
circulating dengue and Chikungunya viruses exhibit symptoms similar to ZIKV, and (ii) the 152 
Brazilian case reporting system has evolved through time (Methods). We estimated basic 153 
reproductive numbers (R0) for ZIKV in each Brazilian region from the weekly notified case 154 
data and found that R0 is high in NE Brazil (R0~3 for both epidemic seasons; Extended Data 155 
Table 1c). Although our R0 values are approximate, in part due to spatial variation in 156 
transmission across the large regions analysed here, they are consistent with estimates from 157 
other approaches15,16. 158 
Encouraged by the utility of portable genomic technologies during the West African Ebola 159 
virus epidemic17 we used our open protocol18 to sequence ZIKV genomes directly from 160 
clinical material using MinION DNA sequencers. We were able to generate virus sequences 161 
within 48 hours of the mobile lab’s arrival at each LACEN. In pilot experiments using a 162 
cultured ZIKV reference strain19 we recovered 98% of the virus genome (Extended Data Fig. 163 
1c). However, due to low viral copy numbers in clinical samples (Extended Data Fig. 1a) 164 
many sequences exhibited incomplete genome coverage and required additional sequencing 165 
efforts in static labs once fieldwork was completed. Whilst average genome coverage was 166 
typically high for samples with lower Ct-values (85% for Ct<33; Fig. 2a, Extended Data 167 
Table 2), samples with higher Ct values had variable coverage (mean=72% for Ct≥33 (Fig. 168 
2a). Unsequenced genome regions were non-randomly distributed (Fig. 2b) suggesting that 169 
the efficiency of PCR amplification varied among primer pair combinations. We generated 36 170 
near-complete or partial genomes from the NE, SE and N regions of Brazil, supplemented by 171 
9 sequences from samples from Rio de Janeiro municipality. To further elucidate Zika virus 172 
transmission in the Americas, we include 5 new ZIKV complete genomes from Colombia and 173 
4 from Mexico. Further, we append to our dataset 115 publicly available sequences and 85 174 
additional genomes from a companion paper20. The final dataset comprised 254 ZIKV 175 
sequences, 241 of which were sampled in the Americas (Methods). 176 
The American ZIKV epidemic comprises a single founder lineage4,21,22 (hereafter termed Am-177 
ZIKV) derived from Asian genotype viruses (hereafter termed PreAm-ZIKV) from Southeast 178 
Asia and the Pacific4. A sliding window analysis of pairwise genetic diversity along the ZIKV 179 
genome shows that the diversity of PreAm-ZIKV strains is on average ~2.1-fold greater than 180 
Am-ZIKV viruses (Fig. 2d), reflecting a longer period of ZIKV circulation in Asia and the 181 
Pacific than in the Americas. Genetic diversity of Am-ZIKV strains will increase in future 182 
and updated diagnostic assays are recommended to guarantee RT-qPCR sensitivity23. 183 
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It has been suggested that recent ZIKV epidemics may be linked causally to a higher apparent 184 
evolutionary rate for the Asian genotype than the African genotype24,25. However, such 185 
comparisons are confounded by an inverse relationship between the timescale of observation 186 
and estimated evolutionary rates26. Regression of sequence sampling dates against root-to-tip 187 
genetic distances indicates that molecular clock models can be applied reliably to the Asian-188 
ZIKV lineage (Fig. 2c; Extended Data Figs. 2,3). We estimate the whole genome 189 
evolutionary rate of Asian ZIKV to be 0.97x10-3 substitutions per site per year (s/s/y; 95% 190 
Bayesian credible interval, BCI=0.87-1.01x10-3), consistent with other estimates for this 191 
lineage4,25. We found no significant differences in evolutionary rates among ZIKV genome 192 
regions (Extended Data Table 3a). The estimated dN/dS ratio of the Am-ZIKV lineage is low 193 
(0.11, 95% CI= 0.10-0.13), as observed for other vector-borne flaviviruses27 but is higher than 194 
that of PreAm-ZIKV viruses (0.061, 0.047-0.077), likely due to the raised probability of 195 
observing slightly deleterious changes in short-term datasets, as observed during previous 196 
epidemics28. 197 
We used two phylogeographic approaches with different assumptions29,30 to reconstruct the 198 
origins and spread of ZIKV in Brazil and the Americas. We dated the common ancestor of 199 
ZIKV in the Americas (node B, Fig. 3) to Jan 2014 (95% BCIs=Oct 2013-Apr 2014; 200 
Extended Data Tables 3b,c), in line with previous estimates4,25. We find evidence that NE 201 
Brazil played a central role in the establishment and dissemination of Am-ZIKV. Whilst NE 202 
Brazil is the most probable location of node B (location posterior support=0.83, Fig. 3), 203 
current data cannot exclude the hypothesis that node B was in the Caribbean (Fig. 3 dashed 204 
branches) due the presence of two sequences from Haiti in one of its descendant lineages. 205 
More importantly, most Am-ZIKV sequences descend from a radiation of lineages (node C 206 
and its immediate descendants; Fig. 3) dated to late Feb 2014 (95% BCIs of node C=Dec 207 
2013-Jun 2014). Node C is more strongly inferred to have existed in NE Brazil (location 208 
posterior support=0.99, Fig. 3). All 20 replicate analyses performed on sub-sampled data sets 209 
place node C in Brazil, 14 of which place node C in NE Brazil (Extended Data Fig. 4). 210 
Consequently, we conclude that node C reflects the crucial turning point in the emergence of 211 
ZIKV in the Americas. If further data show that node B did indeed exist in Haiti, then it is 212 
likely that Haiti acted as an intermediate ‘stepping stone’ for Am-ZIKV’s arrival and 213 
establishment in Brazil, from where the virus subsequently spread to other regions. This 214 
perspective is consistent with the lower population size of Haiti compared to Brazil. We infer 215 
that node C was present in NE Brazil several months before three notable events, each of 216 
which also occurred in NE Brazil: (i) the retrospective identification of a cluster of suspected 217 
but unconfirmed ZIKV cases in Dec 20141, (ii) the oldest ZIKV genome sequence from 218 
Brazil, reported here, sampled in Feb 2015, and (iii) confirmed cases of ZIKV transmission in 219 
NE Brazil in Mar 201531,32. 220 
Our results further indicate that viruses from NE Brazil were important in the continental 221 
spread of ZIKV. Within Brazil, we find instances of virus lineage movement from NE to SE 222 
Brazil; most of these events are dated to the second half of 2014 and led to onwards 223 
transmission in Rio de Janeiro (RJ1 to RJ4; Fig. 3) and São Paulo states (SP1; Fig. 3). We 224 
infer that ZIKV lineages disseminated from NE Brazil to elsewhere in Central America, the 225 
Caribbean, and South America. Most Am-ZIKV strains sampled outside Brazil fall into four 226 
well-supported phylogenetic groups (Fig 3); three (SA1/CB1, CA1 and SA2) are inferred to 227 
have been exported from NE Brazil between Jul 2014 and Apr 2015, while the Caribbean 228 
clade CB2 appears to originate from SE Brazil around Mar 2015 (Figs. 3, 4). Each viral 229 
lineage export occurred during a period of climatic suitability for vector transmission in the 230 
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recipient location (Fig. 4). For the earliest exports to Central America (CA1) and South 231 
America (SA1), there is a 7-9 month gap between the estimated date of exportation and the 232 
date of ZIKV detection in the recipient location, suggesting a complete or partial season of 233 
undetected transmission. These periods of cryptic transmission are relevant to studies of 234 
spatio-temporal trends in reported microcephaly, because they help to define the appropriate 235 
timeframe for baseline (pre-ZIKV) microcephaly in each region. 236 
Large-scale surveillance of ZIKV is challenging because (i) many cases may be 237 
asymptomatic and (ii) ZIKV co-circulates in some regions with other arthropod-borne viruses 238 
with overlapping symptoms (e.g. dengue, Chikungunya, Mayaro, and Oropouche viruses). 239 
However combining virus genomic and epidemiological data can generate insights into 240 
vector-borne virus transmission. A system of continuous and structured virus sequencing in 241 
Brazil, integrated with surveillance data, could provide timely information to inform effective 242 
responses against Zika and other viruses, including the recently re-emerged yellow fever 243 
virus33.  244 
 245 
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Fig. 1. Geographic and temporal distribution of ZIKV in Brazil. a. Sampling location of 403 
genome sequences from Brazil and the Americas. Federal states in Brazil are coloured 404 
according to 5 geographic regions (lower inset). A red line surrounds the states surveyed by 405 
the ZiBRA mobile lab in 2016. State codes are PA=Pará, MA=Maranhão, CE=Ceará, 406 
TO=Tocantins, RN=Rio Grande do Norte, PB=Paraíba, PE=Pernambuco, AL=Alagoas, 407 
BA=Bahia, RJ=Rio de Janeiro, SP=São Paulo. Underlined states represent those from which 408 
sequences in this study were generated (upper inset). Publicly available sequences were also 409 
collated from non-underlined states. b. Confirmed and notified ZIKV cases in NE Brazil. 410 
Upper panel shows the temporal distribution of RT-qPCR+ cases detected during ZiBRA 411 
fieldwork. Only samples with known collection dates are included (n=138 out of 181 412 
confirmed cases). Lower panel shows notified ZIKV cases in NE Brazil between 01 Jan 2015 413 
and 19 Nov 2016 (n=122,779).  The dashed line represents the average climatic vector 414 
suitability score for NE Brazil (Methods). The vertical arrow indicates date of ZIKV 415 
confirmation in NE Brazil/Americas1. c. Notified ZIKV cases in the Centre-West, Southeast, 416 
North, and South regions of Brazil (clockwise from top left). The dashed lines represent the 417 
average climatic vector suitability score for each region.  418 
 419 
Fig. 2. Zika virus genetic diversity and sequencing statistics. a. The percentage of ZIKV 420 
genome sequenced plotted against RT-qPCR Ct-value, for each sample. Each circle represents 421 
a sequence recovered from an infected individual in Brazil and is coloured by sampling 422 
location. b. Illustration of sequencing coverage across the ZIKV genome for the ZiBRA 423 
sequences, including data generated by both mobile and static laboratories. c. Regression of 424 
sequence sampling dates against root-to-tip genetic distances in a maximum likelihood 425 
phylogeny of the Asian-ZIKV lineage. Extended Data Fig. 2b contains a comparable 426 
analysis that also includes P6-740 (the oldest Asian-ZIKV strain collected in 1966). d. 427 
Average pairwise genetic diversity of the PreAm-ZIKV strains (grey line) and of the Am-428 
ZIKV lineage (black line), calculated using a sliding window of 300 nucleotides with a step 429 
size of 50 nucleotides.  430 
 431 
Fig. 3. Phylogeography of ZIKV in the Americas. Maximum clade credibility phylogeny, 432 
estimated from complete and partial Am-ZIKV genomes using a molecular clock 433 
phylogeographic approach (Methods). Terminal branches with yellow circles indicate 434 
sequences reported in this study. Terminal branches with no circles and reduced opacity are 435 
those reported in a companion paper20. Thin vertical grey boxes indicate statistical uncertainty 436 
of estimated dates of nodes A, B and C (Extended Data Table 3c). Branch colours indicate 437 
the most probable ancestral lineage locations. Diamonds at internal nodes are sized in 438 
proportion to clade posterior probabilities. For selected nodes, coloured numbers show the 439 
posterior probabilities of ancestral locations and numbers in grey are clade posterior 440 
probabilities. Asterisks indicate the three available genomes from microcephaly cases. A 441 
black arrow indicates the oldest Brazilian ZIKV sequence. The grey arrow and dotted line 442 
denotes when ZIKV was first confirmed in the Americas1. Nodes A and B are equivalent to 443 
the nodes named identically in4. Text labels along the bottom of the figure denote clades of 444 
sequences from regions outside of NE Brazil. RJ1 to RJ4 are clades from Rio de Janeiro state, 445 
TO from Tocantins, and SP1 from São Paulo state. Clades from outside Brazil are denoted 446 
CB1 and CB2 (Caribbean), SA1 and SA2 (South America excluding Brazil), and CA1 447 
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(Central America). Thin grey horizontal lines along the bottom of the figure denote sequences 448 
from Brazil.  449 
 450 
Fig. 4. Establishment of Am-ZIKV in the Americas. The earliest inferred dates of lineage 451 
export to non-Brazilian regions, represented by box-and-whisker plots. Each plot corresponds 452 
to the earliest movement between a pair of locations with well-supported virus lineage 453 
migration. The first exports to South America outside Brazil (SA1 in Fig. 3), to Central 454 
America (CA1) and to the Caribbean (CB1) are shown in panels a-c, respectively. Box and 455 
whisker plots were generated in ggplot2, with boxes representing the median and interquartile 456 
ranges of the estimated date of earliest movement. In each of a-c, dashed lines show the 457 
estimated climatic vector suitability score for each recipient region, averaged across the 458 
countries for which sequence data is available (see Methods). In each of a-c, the bar plots 459 
show available notified ZIKV case data (plots adapted from PAHO) for the countries with the 460 
earliest confirmed cases (Colombia61 in panel a, Mexico62 in b, and Puerto Rico63 in c). 461 
Coloured arrows indicate the earliest confirmation of ZIKV autochthonous cases in each non-462 
Brazilian region. The vertical dashed line represents the date of ZIKV confirmation in the 463 
Americas. 464 
  465 
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Methods 466 
Sample collection 467 
Between the 1st and 18th June 2016, 1330 samples from cases notified as ZIKV infected were 468 
tested for ZIKV infection in the Northeast region of Brazil (NE Brazil). During this period, 4 469 
of the 5 laboratories in the region visited by the ZiBRA project were in the process of 470 
implementing molecular diagnostics for ZIKV. The ZiBRA team spent 2-3 days in each state 471 
central public health laboratory (LACEN). The samples analysed had been previously 472 
collected from patients who had attended a municipal or state public health facility, 473 
presenting maculopapular rash and at least two of the following symptoms: fever, 474 
conjunctivitis, polyarthralgia, or periarticular edema. The majority of samples were linked to 475 
a digital record that collated epidemiological and clinical data: date of sample collection, 476 
location of residence, demographic characteristics, and date of onset of clinical symptoms 477 
(when available).  478 
The ZiBRA project was supported by the Brazilian Ministry of Health (MoH) as part of the 479 
emergency public health response to Zika. Samples had been previously obtained for routine 480 
diagnostic purposes from persons visiting local clinics by the Brazilian National Health 481 
Surveillance network as part of Zika virus surveillance activities. In these cases, we used 482 
samples without informed consent with the approval of the Brazilian Ministry of Health. 483 
Specifically, residual anonymised clinical diagnostic samples, with no or minimal risk to 484 
patients, were provided for research and surveillance purposes within the terms of Resolution 485 
510/2016 of CONEP (Comissão Nacional de Ética em Pesquisa, Ministério da Saúde; 486 
National Ethical Committee for Research, Ministry of Health). For samples obtained from 487 
patients engaged in longitudinal studies of Zika virus in São Paulo and Tocantins states, 488 
informed consent was obtained (IRB CAAE 53153916.7.0000.0065). Samples from patients 489 
followed in Salvador and Feira de Santana were analysed under institutional approval from 490 
CPqGM/FioCruz/BA (1.184.454). Urine and plasma samples from Rio de Janeiro were 491 
obtained from patients at the Fiocruz Viral Hepatitis Ambulatory (Oswaldo Cruz Institute, 492 
Rio de Janeiro, Brazil) with Institutional Review Board approval (IRB142/01) from the 493 
Oswaldo Cruz Institute. RNA was extracted at the Paul-Ehrlich-Institut and sequenced at the 494 
University of Birmingham, UK. 495 
Nucleic acid isolation and RT-qPCR 496 
Serum, blood and urine samples were obtained from patients 0 to 228 days after first 497 
symptoms (Extended Data Table 1a). Viral RNA was isolated from 200 Pl Zika-suspected 498 
samples using either the NucliSENS easyMag system (BioMerieux, Basingstoke, UK) 499 
(Ribeirão Preto samples), the ExiPrep Dx Viral RNA Kit (BIONEER, Republic of Korea) 500 
(Rio de Janeiro samples) or the QIAamp Viral RNA Mini kit (QIAGEN, Hilden, Germany) 501 
(all other samples) according to the manufacturer’s instructions. Ct values were determined 502 
for all samples by probe-based RT-qPCR against the prM target (using 5’FAM as the probe 503 
reporter dye) as previously described34. RT-qPCR assays were performed using the 504 
QuantiNova Probe RT-qPCR Kit (20 ul reaction volume; QIAGEN) with amplification in the 505 
Rotor-Gene Q (QIAGEN) following the manufacturer’s protocol. Primers/probe were 506 
synthesised by Integrated DNA Technologies (Leuven, Belgium). The following reaction 507 
conditions were used: reverse transcription (50°C, 10 min), reverse transcriptase inactivation 508 
and DNA polymerase activation (95°C, 20 sec), followed by 40 cycles of DNA denaturation 509 
(95°C, 10 secs) and annealing-extension (60°C, 40 sec). Positive and negative controls were 510 
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included in each batch; however, due to the large number of samples tested in a short time it 511 
was possible only to run each sample without replication.  512 
Whole genome sequencing 513 
Sequencing was attempted on all positive samples obtained from NE Brazil regardless of Ct 514 
value. All samples collected in Brazil that are reported in this study were sequenced with the 515 
Oxford Nanopore MinION. Sequencing statistics can be found in Extended Data Table 2. 516 
The protocol employed cDNA synthesis with random primers followed by gene specific 517 
multiplex PCR and is presented in detail in Quick et al. 18. In brief, extracted RNA was 518 
converted to cDNA using the Protoscript II First Strand cDNA synthesis Kit (New England 519 
Biolabs, Hitchin, UK) and random hexamer priming. ZIKV genome amplification by 520 
multiplex PCR was attempted using the ZikaAsianV1 primer scheme and 40 cycles of PCR 521 
using Q5 High-Fidelity DNA polymerase (NEB) as described in Quick et al.18. PCR products 522 
were cleaned-up using AmpureXP purification beads (Beckman Coulter, High Wycombe, 523 
UK) and quantified using fluorimetry with the Qubit dsDNA High Sensitivity assay on the 524 
Qubit 3.0 instrument (Life Technologies). PCR products for samples yielding sufficient 525 
material were barcoded and pooled in an equimolar fashion using the Native Barcoding Kit 526 
(Oxford Nanopore Technologies, Oxford, UK). Sequencing libraries were generated from the 527 
barcoded products using the Genomic DNA Sequencing Kit SQK-MAP007/SQK-LSK208 528 
(Oxford Nanopore Technologies). Sequencing libraries were loaded onto a R9/R9.4 flowcell 529 
and data was collected for up to 48 hours but generally less. As described18, consensus 530 
genome sequences were produced by alignment of two-direction reads to a Zika virus 531 
reference genome (strain H/PF/2013, GenBank Accession number: KJ776791) followed by 532 
nanopore signal-level detection of single nucleotide variants. Only positions with ≥20x 533 
genome coverage were used to produce consensus alleles. Regions with lower coverage, and 534 
those in primer-binding regions were masked with N characters. Validation of our sequencing 535 
approach on the MinION platform was undertaken by using the MinION platform to sequence 536 
a WHO reference strain of Zika virus that was also sequenced using the Illumina Miseq 537 
platform19; identical consensus sequences were recovered regardless of the MinION 538 
chemistry version employed (R7.3, R9 and R9.4) (Extended Data Fig. 1c). 539 
 540 
Collation of genome-wide data sets 541 
Our complete and partial genome sequences were appended to a global data set of all 542 
available published ZIKV genome sequences (up until January 2017) using an in-house script 543 
that retrieves updated GenBank sequences on a daily basis. In addition to the genomes 544 
generated from samples collected in NE Brazil during ZiBRA fieldwork, samples were sent 545 
directly to University of São Paulo and elsewhere for sequencing. Thirteen genomes from 546 
Ribeirão Preto, São Paulo state (SP; SE-Brazil region) and seven genomes from Tocantins 547 
(TO; N-Brazil region) were sequenced at University of São Paulo. Nine genomes from Rio de 548 
Janeiro (RJ; SE-Brazil region) were sequenced in Birmingham, UK, and added to our dataset. 549 
All these genomes were generated using the same primer scheme as the ZiBRA samples 550 
collected in NE Brazil18. In addition to these 45 sequences from Brazil, we further included in 551 
analysis 9 genomes from ZIKV strains sampled outside of Brazil in order to contextualise the 552 
genetic diversity of Brazilian ZIKV, giving rise to a final data set of 54 sequences. 553 
Specifically, we included 5 genomes from samples collected in Colombia and 4 new genomes 554 
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from Mexico, which were generated using the protocols described in refs. 35 and 22, 555 
respectively.  556 
GenBank sequences belonging to the African genotype of ZIKV were identified using the 557 
Arboviral genotyping tool (http://bioafrica2.mrc.ac.za/rega-genotype/typingtool/aedesviruses) 558 
and excluded from subsequent analyses, as our focus of study was the Asian genotype of 559 
ZIKV, and the Am-ZIKV lineage in particular. To assess the robustness of molecular clock 560 
dating estimates to the inclusion of older sequences, analyses were performed both with and 561 
without the P6-740 strain, the oldest known strain of the ZIKV-Asian genotype (sampled in 562 
1966 in Malaysia). Our final alignment comprised the sequences reported in this study (n=54) 563 
plus publicly available ZIKV-Asian genotype sequences, as of 1st March 2017 (n=115). We 564 
also included in our analysis 85 additional genomes from a companion paper20. The dataset 565 
used for analysis therefore included sequences from 254 Zika virus isolates, 241 of which 566 
were from the Americas. Unpublished but publicly available genomes were included in our 567 
analysis only if we had written permission from those who generated the data (see 568 
Acknowledgments).   569 
 570 
Maximum likelihood analysis and recombination screening 571 
Preliminary maximum likelihood (ML) trees were estimated with ExaMLv336 using a per-site 572 
rate category model and a gamma distribution of among site rate variation. For the final 573 
analyses, ML trees were estimated using PhyML37 under a GTR nucleotide substitution 574 
model38, with a gamma distribution of among site rate variation, as selected by 575 
jModeltest.v.239.  Branch support was inferred using 100 bootstrap replicates37. Final ML 576 
trees were estimated with NNI and SPR heuristic tree search algorithms; equilibrium 577 
nucleotide frequencies and substitution model parameters were estimated using ML37 (see 578 
Extended Data Fig. 3).  579 
Recombination may impact evolutionary estimates40 and has been shown to be present in the 580 
ZIKV-African genotype41. In addition to restricting our analysis to the Asian genotype of 581 
ZIKV, we employed the 12 recombination detection methods available in RDPv442 and the 582 
Phi-test approach43 available in SplitsTree44 to further search for evidence of recombination in 583 
the ZIKV-Asian lineage. No evidence of recombination was found. 584 
Analysis of the temporal molecular evolutionary signal in our ZIKV alignments was 585 
conducted using TempEst45. In brief, collection dates in the format yyyy-mm-dd (ISO 8601 586 
standard) were regressed against root-to-tip genetic distances obtained from the ML 587 
phylogeny. When precise sampling dates were not available, a precision of 1 month or 1 year 588 
in the collection dates was taken into account.  589 
To compare the pairwise genetic diversity of PreAm-ZIKV strains from Asia and the Pacific 590 
with Am-ZIKV viruses from the Americas, we used a sliding window approach with 300 nt 591 
wide windows and a step size of 50 nt. Sequence gaps were ignored; hence the average 592 
pairwise difference per window was obtained by dividing the total pairwise nucleotide 593 
differences by the total number of pairwise comparisons.  594 
 595 
Molecular clock phylogenetics and gene-specific dN/dS estimation 596 
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To estimate Bayesian molecular clock phylogenies, analyses were run in duplicate using 597 
BEASTv.1.8.446 for 30 million MCMC steps, sampling parameters and trees every 3000 598 
steps. We employed a model selection procedure using both path-sampling and stepping stone 599 
models47 to estimate the most appropriate combination of molecular clock and coalescent 600 
models for Bayesian phylogenetic analysis. The best fitting combination was a Bayesian 601 
skyline tree prior and a relaxed molecular clock model, with log-normally distributed 602 
variation in rates among branches (Extended Data Table 3b). A non-informative continuous 603 
time Markov chain reference prior49 on the molecular clock rate was used. Convergence of 604 
MCMC chains was checked with Tracer v.1.6. After removal of burn-in, posterior tree 605 
distributions were combined and subsampled to generate an empirical distribution of 1,500 606 
molecular clock trees.  607 
To estimate rates of evolution per gene we partitioned the alignment into 10 genes (3 608 
structural genes C, prM, E, and 7 non-structural genes NS1, NS2A, NS2B, NS3, NS4A, NS4B 609 
and NS5) and employed a SDR06 substitution model48 and a strict molecular clock model, 610 
using an empirical distribution of molecular clock phylogenies. To estimate the ratio of 611 
nonsynonymous to synonymous substitutions per site (dN/dS) for the PreAm-ZIKV and the 612 
Am-ZIKV lineages, we used the single likelihood ancestor counting (SLAC) method50 613 
implemented in HyPhy51. This method was applied to two distinct codon-based alignments 614 
and their corresponding ML trees which comprised the PreAm-ZIKV and Am-ZIKV 615 
sequences, respectively. 616 
 617 
Phylogeographic analysis  618 
We investigated virus lineage movements using our empirical distribution of phylogenetic 619 
trees and the sampling location of each ZIKV sequence. The sampling location of sequences 620 
collected from returning travellers was set to the travel destination in the Americas where 621 
infection likely occurred. We discretised sequence sampling locations in Brazil into the 622 
geographic regions defined in the main text. The number of sequences per region available for 623 
analysis was 10 for N Brazil, 41 for NE Brazil and 54 for SE Brazil. No viral genetic data was 624 
available for the Centre-West (CW) and the South (S) Brazilian regions. We similarly 625 
discretised the locations of ZIKV sequences sampled outside of Brazil. These were grouped 626 
according to the United Nations M49 coding classification of macro-geographical regions. 627 
Our analysis included 53 sequences from the Caribbean, 38 from Central America, 17 from 628 
Polynesia, 37 from South America (excluding Brazil), 3 from Southeast Asia and 1 from 629 
Micronesia. To account for the possibility of sampling bias arising from a larger number of 630 
sequences from particular locations, we repeated all phylogeographic analyses using (i) the 631 
full dataset (n=254) and (ii) ten jackknife resampled datasets (n=74) in which taxa from each 632 
location (except for Southeast Asia and Micronesia) were randomly sub-sampled to 10 633 
sequences (the number of sequences available for N-Brazil).  634 
Phylogeographic reconstructions were conducted using two approaches; (i) using the 635 
asymmetric52 discrete trait evolution models implemented in BEASTv1.8.446 and (ii) using 636 
the Bayesian structured coalescent approximation (BASTA)29 implemented in BEAST2v.2. 637 
The latter has been suggested to be less sensitive to sampling biases53. For both approaches, 638 
maximum clade credibility trees were summarized from the MCMC samples using 639 
TreeAnnotator after discarding 10% as burn-in. The posterior estimates of the location of 640 
 18 
nodes A, B and C (depicted in Fig. 3) from these two analytical approaches (applied to both 641 
the complete and jackknifed data sets) can be found in Extended Data Fig. 4. 642 
For the discrete trait evolution approach, we counted the expected number of transitions 643 
among each pair of locations (net migration) using the robust counting approach54,55 available 644 
in BEASTv1.8.446. We then used those inferred transitions to identify the earliest estimated 645 
ZIKV introductions into new regions. These viral lineage movement events were statistically 646 
supported (with Bayes factors > 3) using the BSSVS (Bayesian stochastic search variable 647 
selection) approach implemented in BEASTv.1.8.430. Box plots for node ages were generated 648 
using the ggplot256 package in R software57.  649 
 650 
Epidemiological analysis 651 
Weekly suspected ZIKV data per Brazilian region were obtained from the Brazilian Ministry 652 
of Health (MoH). Cases were defined as suspected ZIKV infection when patients presented 653 
maculopapular rash and at least two of the following symptoms: fever, conjunctivitis, 654 
polyarthralgia or periarticular edema. Because notified suspected ZIKV cases are based on 655 
symptoms and not molecular diagnosis, it is possible that some notified cases represent other 656 
co-circulating viruses with related symptoms, such as dengue and Chikungunya viruses. 657 
Further, case reporting may have varied among regions and through time. Data from 2015 658 
came from the pre-existing MoH sentinel surveillance system that comprised 150 reporting 659 
units throughout Brazil, which was eventually standardised in Feb 2016 in response to the 660 
ZIKV epidemic. We suggest that these limitations should be borne in mind when interpreting 661 
the ZIKV notified case data and we consider the R0 values estimated here to be approximate. 662 
That said, our time series of RT-qPCR+ ZIKV diagnoses from NE Brazil qualitatively match 663 
the time series of notified ZIKV cases from the same region (Fig. 1b). To estimate the 664 
exponential growth rate of the ZIKV outbreak in Brazil, we fit a simple exponential growth 665 
rate model to each stage of the weekly number of suspected ZIKV cases from each region 666 
separately: 667 
 668 
𝐼𝑤 = 𝐼0𝑒𝑥𝑝(𝑟𝑊.𝑤)                                                  (1) 669 
 670 
where 𝐼𝑤 is the number of cases in week w. As described in main text, the Brazilian regions 671 
considered here were NE Brazil, N-Brazil, S-Brazil, SE-Brazil, and CW-Brazil. The time 672 
period over which exponential growth occurs was determined by plotting the log of 𝐼𝑤 and 673 
selecting the period of linearity (Extended Data Fig. 5). A linear model was then fitted to 674 
this period to estimate the weekly exponential growth rate 𝑟𝑊: 675 
 676 
𝑙𝑛(𝐼𝑤) = 𝑙𝑛(𝐼0) + 𝑟𝑊.𝑤                                              (2) 677 
 678 
Let 𝑔(. )  be the probability density distribution of the epidemic generation time (i.e. the 679 
duration between the time of infection of a case and the mean time of infection of its 680 
secondary infections). The following formula can be used to derive the reproduction number 681 
R from the exponential growth rate 𝑟 and density 𝑔(∙)58. 682 
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 683 
𝑅 = 1
∫ 𝑒𝑥𝑝(−𝑟.𝑡)𝑔(𝑡)𝑑𝑡
∞
0
                                                  (3) 684 
In our baseline analysis, following Ferguson et al.59 we assume that the ZIKV generation time 685 
is Gamma-distributed with a mean of 20.0 days and a standard deviation (SD) of 7.4 days. In 686 
a sensitivity analysis, we also explored scenarios with shorter mean generation times (10.0 687 
and 15.0 days) but unchanged coefficient of variation SD/mean=7.4/20=0.37 (Extended Data 688 
Table 1c). 689 
 690 
Association between Aedes aegypti climatic suitability and ZIKV notified cases 691 
To account for seasonal variation in the geographical distribution of the ZIKV vector Aedes 692 
aegypti in Brazil we fitted high-resolution maps60 to monthly covariate data. Covariate data 693 
included time-varying variables, such as temperature-persistence suitability, relative 694 
humidity, and precipitation, as well as static covariates such as urban versus rural land use. 695 
Maps were produced at a 5km x 5km resolution for each calendar month and then aggregated 696 
to the level of the five Brazilian regions used in this study (Extended Data Fig. 6). For 697 
consistency, we rescaled monthly suitability values so that the sum of all monthly maps 698 
equalled the annual mean map9. 699 
We then assessed the correlation between monthly Aedes aegypti climatic suitability and the 700 
number of weekly ZIKV notified cases in each Brazilian region, to test how well vector 701 
suitability explains the variation in the number of ZIKV notified cases. To account for the 702 
correlation in each Brazilian region we fit a linear regression model with a lag and two 703 
breakpoints. As there may be a lag between trends in suitability and trends in notified cases, 704 
we include a temporal term in the model to allow for a shift in the respective curves. Thus for 705 
each region, different sets of the constant and linear terms are fitted to different time periods. 706 
More formally, 707 
 708 
  log⁡(𝑦𝑖 + 1) = 𝛼 + 𝕀(𝑖 ∉ 𝑇)𝛼′ + [𝑏 + 𝕀(𝑖 ∉ 𝑇)𝑏′]𝑥𝑖−𝑙  (4) 709 
 710 
where yi represents notified cases in a particular region in month i, xi is the climatic 711 
suitability in that region in month i, l is the time lag that yields the highest correlation 712 
between yi and xi and T is the set of time indexes in the correlated region.  713 
We then find the values of T and l that provide the highest adjusted-R2 by stepwise iterative 714 
optimisation. For each value of T evaluated, the optimal value of l (i.e. that which gives the 715 
highest adjusted-R2 for the model above) is found by the optim function in R57. Climatic 716 
suitability values were only calculated for each month, so to calculate suitability values for 717 
any given point in time we interpolated between the monthly values using a linear function. 718 
We found no significant effect of residual autocorrelation in our data (Extended Data Fig. 719 
7). 720 
 721 
Data availability 722 
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Details of the primers and probes used here have been available at 723 
http://www.zibraproject.org since the beginning of the project. BEAST XML files, tree files, 724 
and sequence datasets analysed in this study are archived at 725 
https://github.com/zibraproject. New Brazilian sequences are available in GenBank under 726 
accession numbers KY558989 to KY559032 and KY817930. New Colombian and Mexican 727 
sequences are available under accession numbers KY317936-40 and KY606271-4, 728 
respectively. See Extended Data Table 2 for further details. 729 
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Extended Data Figure Legends 815 
Extended Data Fig. 1. a. The distribution of CT-values for the RT-qPCR+ samples tested 816 
during the ZiBRA journey in Brazil (n=181 samples; median CT = 35.96). b. shows the 817 
distribution of the temporal lag between the date of onset of clinical symptoms and the date of 818 
sample collection of RT-qPCR+ samples (median lag = 2 days). Red dashed lines represent 819 
the median of the distributions. (c) Validation of sequencing approaches. A phylogeny of the 820 
ZIKV Asian genotype estimated using PhyML37 is shown. The expanded clade highlighted in 821 
blue contains the WHO reference ZIKV sequence19 (accession number KX369547), which 822 
was generated using Illumina MiSeq. Sequences generated using MinION chemistries R9.4 823 
2D, R9.4 1D, R9 1D, R9 2D and R7.3 2D contain no nucleotide differences and hence were 824 
also placed in this clade. Scale bars represent expected nucleotide substitutions per site (s/s). 825 
Am-ZIKV=American Zika virus lineage. 826 
 827 
Extended Data Fig. 2. Temporal signal of the ZIKV Asian genotype. The correlation 828 
between sampling dates and genetic distances from the tips to the root of a maximum 829 
likelihood (ML) tree, estimated using PhyML37, was explored using TempEst45. a. Estimates 830 
for the dataset used in the phylogenetic analysis presented in Fig. 3c, and b. estimates for the 831 
same dataset with the addition of the P6-740 strain sampled in 1966 (accession number 832 
HQ234499).  833 
 834 
Extended Data Fig. 3. A non-clock maximum likelihood phylogeny of our ZIKV data set. 835 
Bootstrap branch support values are shown at each node. The phylogeny was estimated using 836 
PhyML37. Sequences generated in this study are highlighted in red. Scale bar represents 837 
expected nucleotide substitutions per site. 838 
 839 
Extended Data Fig. 4. Ancestral node location posterior probabilities (ANLPP), for nodes A, 840 
B and C, estimated using the complete dataset (top row) and ten replicate subsampled data 841 
sets (other rows). See Methods for details. ANLPPs were calculated using two approaches: 842 
DTA=discrete trait analysis method30 (left side columns) and BASTA=Bayesian structured 843 
coalescent approximation method29 (right side columns). For each method, we employed an 844 
asymmetric model of location exchange to estimate ancestral node locations and to infer 845 
patterns of virus spread among regions. 846 
 847 
Extended Data Fig. 5. Epidemic growth rates estimated from weekly ZIKV notified cases in 848 
Brazil. Time series show the number of ZIKV notified cases in each region of Brazil. Periods 849 
from which exponential growth were estimated are highlighted in grey.  850 
 851 
Extended Data Fig. 6. Seasonal suitability for ZIKV transmission in the Americas. These 852 
maps were estimated by collating data on Aedes mosquitoes, temperature, relative humidity 853 
 24 
and precipitation, and are the basis of the trends in suitability for different regions shown in 854 
main text Figs. 1 and 4. For method details, see 9,60. 855 
 856 
Extended Data Fig. 7. Partial autocorrelation functions for the linear model associating 857 
climatic suitability and ZIKV notified cases in each geographic region in Brazil. The residuals 858 
for the North, Northeast, Centre-West and Southeast regions show no autocorrelation, while a 859 
small amount of autocorrelation cannot be excluded for the South region.  860 
 25 
Extended Data Table Legends 861 
Extended Data Table 1. a. Summary of the clinical samples tested (n=1330, of which 181 862 
were RT-qPCR+) by the ZiBRA mobile lab in June 2016, NE Brazil. 84% of samples with 863 
known collection dates (n=698 of 826) were from 2016. ZIKV notified cases were 864 
confirmed using RT-qPCR (see Methods). Collection lag represents the median time interval 865 
(in days) between the date of onset of clinical symptoms and date of sample collection (both 866 
dates available for n=219) for all samples (including those that subsequently tested RT-qPCR 867 
negative). Federal states are RN: Rio Grande do Norte, PB: Paraíba, PE: Pernambuco, AL: 868 
Alagoas, BA: Bahia. Sample numbers in the FioCruz, PE row include RT-PCR+ cases from 869 
Pernambuco generated at Fiocruz Pernambuco. b. Parameters of the model measuring the 870 
link between climatic vector suitability and notified ZIKV cases in different Brazilian 871 
regions (CW: Centre-West, N: North, NE: Northeast, SE: Southeast, S: South). For each 872 
region, the table provides the estimated correlated time period (T), P-value of the linear term 873 
of suitability in T, adjusted-R2 of the model, and time lag (l). c. For each region, estimates of 874 
the basic reproductive number (R) of ZIKV are shown for several values of generation time 875 
(g) parameter, together with the corresponding estimates of exponential growth rate (r) (per 876 
day) obtained from notified ZIKV case counts (see Extended Data Fig. 7). 1st: epidemic 877 
wave in 2015; 2nd: epidemic wave in 2016. 878 
 879 
Extended Data Table 2. Sequencing statistics. Accession numbers, sample IDs, sequencing 880 
coverage, RT-qPCR values and epidemiological information for the samples from Brazil 881 
generated in this study. For the sequences from RJ state, alignments were performed against 882 
version 2 (KJ776791.2) of the genome reference; all other sequences used version 1 883 
(KJ776791.1). 884 
 885 
Extended Data Table 3. a. Estimated per-gene rates of evolution (mean and 95% 886 Bayesian credible intervals=BCIs) are shown in units of 10-3 substitutions per site per 887 year. b. Log-marginal likelihood estimates using the path-sampling (PS) and Stepping-888 Stone (SS) model selection approaches47. The overall ranking of the models is shown in 889 parentheses for each estimator and the best-fitting combination is underscored. Two 890 molecular clock models were tested here. SC: Strict clock model, UCLN: uncorrelated 891 relaxed clock with lognormal distribution46. c. Estimated dates of nodes A, B and C (Fig. 892 
3) under various different molecular clock and coalescent model combinations. 893 TMRCA: time of the most recent common ancestor, BCI: Bayesian credible interval, SC: 894 strict molecular clock model, UCLN: uncorrelated clock with lognormal distribution. 895 
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